Our admixed model suggests that immune-mediated clonal selection occurs over a longer period of time, where WT and IFNγRKO tumour cells no longer face equal pressure by CD8+ T cells, and loss of the ability to kill MHC-Ilow cells may be attributed to an increasingly immunosuppressive myeloid compartment. The gene discussed is CD8A; the disease is neoplasm.